2 Result: Theratechnologies
Revised Outlook: Theratechnologies and AngioDynamics Fall Short
July 12th, 2023
Theratechnologies Inc. (Nasdaq: THTX) reported second-quarter fiscal 2023 revenue of $17.549 million, falling short of the consensus estimate of $20.32 million. The company attributes this lower-than-expected revenue to specialty pharmacy inventory a. Read more
Earnings Preview: MillerKnoll, AngioDynamics, and Theratechnologies
July 09th, 2023
On Wednesday, July 12, several companies are expected to report their financial results, including: MillerKnoll, Inc. (Nasdaq: MLKN), a consumer goods company, is set to release its financial results for the fourth quarter and full-year fiscal 202. Read more
Load More Content
Want To Find Some News?
News By Industries
Recent Post
-
Countdown to Earnings: Nutanix, CrowdStrike, and Synopsys on Deck
August 23rd, 2026Investors Eye Semtech, Intuit, and nCino as Earnings Loom
August 22nd, 2026FTC Files Amicus Brief to Protect Competition in Biologic Drug Markets
August 21st, 2026
Member Login